Longitudinal Registry Including Patients Treated With Heavy Particles

ConditionsCancer Oncology Radiation Exposure Radiotherapy Side Effect Radiation Toxicity Rare Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorCNAO National Center of Oncological Hadrontherapy

About this trial

The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia.

By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.

Eligibility criteria

Qualifiers

Patients treated with heavy particles at Fondazione CNAO, Pavia

Patients who have the ability to understand and be willing to sign a written informed consent document

Disqualifiers

Patients or legal guardians who are unable to understand informed consent document

Trial design

Treatments tested in this trial

Heavy-ion therapy (hadrontherapy)

Treatment groups

3,000 Participants

are divided into 8 treatment groups

Treatment groups

See each treatment group below.

Sponsors and collaborators

CNAO National Center of Oncological Hadrontherapy

Lead sponsor

Source ClinicalTrials.gov